Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.59), $0.16 better than the analyst estimate of ($1.75). Revenue for the quarter came in at $30.2 million versus the consensus estimate of $22.69 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.